Baseline Therapeutics
PrivateCompany Overview
Baseline Therapeutics operates in Healthcare & Life Sciences and is based in San Francisco, California. It was founded in 2026.
Baseline Therapeutics is a biotechnology company developing GLP-1 receptor agonist therapeutics for the treatment of addiction disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Baseline Therapeutics Comparables
Compare Baseline Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tempero Bio | 81% | |
| Clearmind Medicine Inc. | 76% | |
| Adial Pharmaceuticals, Inc. | 75% |
For institutional investors. Book with your work email.
Baseline Therapeutics Funding Rounds
Historical fundraising activity
Baseline Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Baseline Therapeutics's valuation, stock price, and market status.
Is Baseline Therapeutics a public or private company?
Baseline Therapeutics is a private company.
What is the current stock price of Baseline Therapeutics?
Baseline Therapeutics is a private company, so its shares have no public market price. Caplight tracks Baseline Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Baseline Therapeutics worth (valuation)?
Valuation information for Baseline Therapeutics is not publicly available.
Can I buy Baseline Therapeutics stock?
Baseline Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Baseline Therapeutics's last funding round?
Funding round information for Baseline Therapeutics is not publicly available.
Who are the main investors in Baseline Therapeutics?
Investor information for Baseline Therapeutics is not publicly disclosed.
Will Baseline Therapeutics IPO soon?
No public IPO plans have been announced for Baseline Therapeutics.
How can I track Baseline Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Baseline Therapeutics's shares on secondary markets.